RE:More optomisticThis sounds like the usual vague statements we've been getting for years. To me Shiseido's statements basically say that they are not even close to commercializing, and they're just putting it on the back burner for 'future research'.
Don't hold your breath for Shiseido.
On the bright side, Replicel has the Dermal Injector that's actually being commercialized. This will bring tangiable revenue to the company and drive up the share price.